Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index; none of the 131 sources its claims cite is checked for support yet.
Abstract
Pseudomonas aeruginosa is a major cause of life-threatening acute infections and life-long lasting chronic infections. The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance, involving physical and physiological factors in addition to biofilm-specific genes that can confer a transient protection against antibiotics promoting the development of resistance. Indeed, a striking feature of this pathogen is the extraordinary capacity to develop resistance to nearly all available antibiotics through the selection of chromosomal mutations, evidenced by its outstanding and versatile mutational resistome. This threat is dramatically amplified in chronic infections, driven by the frequent emergence of mutator variants with enhanced spontaneous mutation rates. Thus, this mini review is focused on describing the complex interplay of antibiotic resistance mechanisms in P. aeruginosa biofilms, to provide potentially useful information for the design of effective therapeutic strategies.
Overview
CoChat Summary
TL;DR
This mini-review describes how *Pseudomonas aeruginosa* biofilms combine transient antibiotic tolerance mechanisms with conventional resistance mechanisms, including mutational resistance and horizontal gene transfer. It argues that biofilm physiology and population structure create a favorable environment for resistance emergence and discusses therapeutic strategies targeting biofilm-specific vulnerabilities.
Key findings
- Biofilm tolerance involves matrix binding/penetration delay, nutrient and oxygen gradients, low metabolic activity, persisters (<0.1% of the biofilm population), reduced ROS, upregulated efflux pumps, and adaptive responses such as colistin-induced *pmr*/*arn* and β-lactam-induced AmpC; these confer transient protection rather than conventional resistance.
- Conventional resistance in biofilms includes mutational resistance and horizontal gene transfer. Mutator/hypermutable strains are present in over one-third of studied cystic fibrosis patients with chronic respiratory infections, compared with 10% at chronic infection onset, 6% in the environment, and <1% in acute infections.
- Biofilm-specific gene expression contributes to resistance: *brlR* activates MexAB-oprM and MexEF-oprN efflux pumps and the ABC transporter PA1874-1877 (10 times more expressed in biofilms), and increased *brlR* lowered susceptibility to hydrogen peroxide and five different classes of antibiotics, increasing MICs up to 6-fold.
- Biofilms facilitate horizontal gene transfer via conjugation, transformation, and transduction; conjugation occurs at higher frequencies than in planktonic cultures, and biofilms can act as plasmid reserves preserving multidrug-resistance plasmids. Mixed biofilm communities also show shielding, e.g., PAO1Δ*dacB* resistant mutants were selected for and amplified under cefepime and located in outer biofilm layers surrounding sensitive PAO1.
Methods
- Design: narrative mini-review; no primary experiments or systematic review methodology are reported.
- Data or sample: published literature on *P. aeruginosa* biofilms, antibiotic tolerance/resistance mechanisms, and related in vitro, in vivo, and cystic fibrosis clinical studies; no new sample or dataset is generated.
- Main analysis: synthesis of cited studies and mechanisms, including a figure adapted from Ciofu et al., *Nat Rev*, 2022.
Limitations
- The paper states no limitations.
- Evident: as a mini-review, it lacks systematic search/selection criteria and does not report primary data or quantitative synthesis.
- Evident: its scope is restricted to *P. aeruginosa* biofilms and antibiotic resistance/tolerance mechanisms; the therapeutic strategies discussed are not clinically validated in this paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 3 Not valid · 75 Not checked · 10 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“promoting the development of resistance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Due to the matrix protection, bacterial cells within a biofilm are significantly more recalcitrant to antibiotics and host immune defences than their planktonic counterparts, as shown by in vitro and in vivo evidence [[5], [6], [7], [8]].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“which by itself is intrinsically resistant to many antibiotics”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction > Pseudomonas aeruginosa: a paradigmatic microorganism
What the sources say
- Not checked yetcites [15] Potron A. Poirel L. Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology Int J Antimicrob Agents 45 2015 568 585 10.1016/j.ijantimicag.2015.03.001 25857949 source
- Not checked yetcites [16] Oliver A. Mulet X. López-Causapé C. Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones Drug Resist Updates 21–22 2015 41 59 10.1016/j.drup.2015.08.002 26304792 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the inability to clear the bacteria is directly related to the chronicity of the infections [9,10].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [9] Smith E.E. Buckley D.G. Wu Z. Saenphimmachak C. Hoffman L.R. D’Argenio D.A. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients Proc Natl Acad Sci U S A 103 2006 8487 8492 10.1073/pnas.0602138103 16687478 PMC1482519 source
- Not checked yetcites [10] Oliver A. Mena A. Maciá M.D. Evolution of Pseudomonas aeruginosa pathogenicity: from acute to chronic infections Evol. Biol. Bact. Fungal pathog 2007 John Wiley & Sons, Ltd 433 444 10.1128/9781555815639.ch36 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 88 claims and to verify the 131 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 9
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,158
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203 · cited 1×
“in turn activates DNA release systems further promoting said state, that also contribute to the stabilisation of the biofilm matrix [77,99,104].”
BackgroundSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Bacterial biofilm and associated infections
Jamal, M., Ahmad, W., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., Hussain, T., Ali, M., Rafiq, M., & Kamil, M. A. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.07.012 · Cited by 1,642
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Self-citationNanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Antibiotic tolerance facilitates the evolution of resistance
Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., & Balaban, N. Q. (2017) · Science · doi:10.1126/science.aaj2191 · Cited by 1,251
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Gene expression in Pseudomonas aeruginosa biofilms
Whiteley, M., Bangera, M. G., Bumgarner, R. E., Parsek, M. R., Teitzel, G. M., Lory, S., & Greenberg, E. P. (2001) · Nature · doi:10.1038/35101627 · Cited by 1,183
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
The clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 842
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 726
Self-citationThe interconnection between biofilm formation and horizontal gene transfer
Madsen, J. S., Burmølle, M., Hansen, L. H., & Sørensen, S. J. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00960.x · Cited by 718
Mulcahy, H., Charron-Mazenod, L., & Lewenza, S. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000213 · Cited by 711
Molin, S., & Tolker-Nielsen, T. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00036-3 · Cited by 708
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Role of mutator alleles in adaptive evolution
Taddei, F., Radman, M., Maynard-Smith, J., Toupance, B., Gouyon, P. H., & Godelle, B. (1997) · Nature · doi:10.1038/42696 · Cited by 677
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Self-citationColvin, K. M., Irie, Y., Tart, C. S., Urbano, R., Whitney, J. C., Ryder, C., Howell, P. L., Wozniak, D. J., & Parsek, M. R. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02657.x · Cited by 612
Pseudomonas biofilm matrix composition and niche biology
Mann, E. E., & Wozniak, D. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00322.x · Cited by 606
Cell Death in Pseudomonas aeruginosa Biofilm Development
Webb, J. S., Thompson, L. S., James, S., Charlton, T., Tolker-Nielsen, T., Koch, B., Givskov, M., & Kjelleberg, S. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.15.4585-4592.2003 · Cited by 599
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
Ryder, C., Byrd, M., & Wozniak, D. J. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.09.010 · Cited by 580
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications
Pires, D. P., Oliveira, H., Melo, L. D. R., Sillankorva, S., & Azeredo, J. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7247-0 · Cited by 517
Biofilm-Specific Antibiotic Resistance
Mah, T.-F. (2012) · Future Microbiology · doi:10.2217/fmb.12.76 · Cited by 504
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., Calum, H., Madsen, K. G., Moser, C., Molin, S., et al. (2005) · Microbiology · doi:10.1099/mic.0.27463-0 · Cited by 500
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
High Rates of Conjugation in Bacterial Biofilms as Determined by Quantitative In Situ Analysis
Hausner, M., & Wuertz, S. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.8.3710-3713.1999 · Cited by 486
Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Abe, K., Nomura, N., & Suzuki, S. (2020) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiaa031 · Cited by 467
Tseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466 · cited 1×
“reduce their activity [23,26–28], whereas neutral antibiotics, like ciprofloxacin, penetrate more easily into the biofilms [24].”
BackgroundFauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425 · cited 1×
“1% of the biofilm population, refractory to antibiotics, a kind of spore-like cell state activity that can become active after finishing the treatment [38,39].”
BackgroundThe emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
Zhang, L., & Mah, T.-F. (2008) · Journal of Bacteriology · doi:10.1128/jb.01655-07 · Cited by 385
Rice, S. A., Tan, C. H., Mikkelsen, P. J., Kung, V., Woo, J., Tay, M., Hauser, A., McDougald, D., Webb, J. S., & Kjelleberg, S. (2009) · The ISME Journal · doi:10.1038/ismej.2008.109 · Cited by 380
Meylan, S., Porter, C. B. M., Yang, J. H., Belenky, P., Gutierrez, A., Lobritz, M. A., Park, J., Kim, S. H., Moskowitz, S. M., & Collins, J. J. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.12.015 · Cited by 377
Endogenous oxidative stress produces diversity and adaptability in biofilm communities
Boles, B. R., & Singh, P. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801499105 · Cited by 353
Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation
Kvist, M., Hancock, V., & Klemm, P. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01310-08 · Cited by 353
Extracellular DNA Shields against Aminoglycosides in Pseudomonas aeruginosa Biofilms
Chiang, W.-C., Nilsson, M., Jensen, P. Ø., Høiby, N., Nielsen, T. E., Givskov, M., & Tolker-Nielsen, T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00001-13 · Cited by 351
Proliferation of mutators in A cell population
Mao, E. F., Lane, L., Lee, J., & Miller, J. H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.2.417-422.1997 · Cited by 325
Ciofu, O. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.9 · Cited by 312
Maciá, M. D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3382-3386.2005 · Cited by 309
Self-citationBaker, P., Hill, P. J., Snarr, B. D., Alnabelseya, N., Pestrak, M. J., Lee, M. J., Jennings, L. K., Tam, J., Melnyk, R. A., Parsek, M. R., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501632 · Cited by 284
Heijerman, H., Westerman, E., Conway, S., & Touw, D. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.005 · Cited by 264
The Versatile Mutational Resistome of Pseudomonas aeruginosa
López-Causapé, C., Cabot, G., del Barrio-Tofiño, E., & Oliver, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00685 · Cited by 254
Self-citationHengzhuang, W., Wu, H., Ciofu, O., Song, Z., & Høiby, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-11 · Cited by 238
Increased mutability of Pseudomonas aeruginosa in biofilms
Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J., & Chopra, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn044 · Cited by 234
Herrmann, G., Yang, L., Wu, H., Song, Z., Wang, H., Høiby, N., Ulrich, M., Molin, S., Riethmüller, J., & Döring, G. (2010) · The Journal of Infectious Diseases · doi:10.1086/656788 · Cited by 219
Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance
Eliopoulos, G. M., & Blazquez, J. (2003) · Clinical Infectious Diseases · doi:10.1086/378810 · Cited by 206
Waite, R. D., Papakonstantinopoulou, A., Littler, E., & Curtis, M. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.18.6571-6576.2005 · Cited by 200
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Bagge, N., Hentzer, M., Andersen, J. B., Ciofu, O., Givskov, M., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1168-1174.2004 · Cited by 192
General Mechanisms Leading to Persister Formation and Awakening
Wilmaerts, D., Windels, E. M., Verstraeten, N., & Michiels, J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.03.007 · Cited by 186
Hengzhuang, W., Wu, H., Ciofu, O., Song, Z., & Høiby, N. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06486-11 · Cited by 185
Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A., Doring, G., et al. (2010) · Thorax · doi:10.1136/thx.2009.114512 · Cited by 184
Yu, S., Su, T., Wu, H., Liu, S., Wang, D., Zhao, T., Jin, Z., Du, W., Zhu, M.-J., Chua, S. L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.129 · Cited by 176
Jennings, L. K., Dreifus, J. E., Reichhardt, C., Storek, K. M., Secor, P. R., Wozniak, D. J., Hisert, K. B., & Parsek, M. R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108782 · Cited by 172
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Juan, C., Peña, C., & Oliver, A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw299 · Cited by 170
Self-citationInduction of beta-lactamase production in Pseudomonas aeruginosa biofilm
Giwercman, B., Jensen, E. T., Høiby, N., Kharazmi, A., & Costerton, J. W. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.1008 · Cited by 167
Khakimova, M., Ahlgren, H. G., Harrison, J. J., English, A. M., & Nguyen, D. (2013) · Journal of Bacteriology · doi:10.1128/jb.02061-12 · Cited by 160
Stewart, P. S., Zhang, T., Xu, R., Pitts, B., Walters, M. C., Roe, F., Kikhney, J., & Moter, A. (2016) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2016.12 · Cited by 157 · cited 2×
“inactive cells, to establish the basis for combination therapies [33,36, 37].”
BackgroundContribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms
Stewart, P. S., Franklin, M. J., Williamson, K. S., Folsom, J. P., Boegli, L., & James, G. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-15 · Cited by 156
Insight into the microbial multicellular lifestyle via flow‐cell technology and confocal microscopy
Pamp, S. J., Sternberg, C., & Tolker‐Nielsen, T. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20685 · Cited by 155
Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies
Yin, R., Cheng, J., Wang, J., Li, P., & Lin, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.955286 · Cited by 151
Waite, R. D., Paccanaro, A., Papakonstantinopoulou, A., Hurst, J. M., Saqi, M., Littler, E., & Curtis, M. A. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-162 · Cited by 147
Kragh, K. N., Alhede, M., Jensen, P. Ø., Moser, C., Scheike, T., Jacobsen, C. S., Seier Poulsen, S., Eickhardt-Sørensen, S. R., Trøstrup, H., Christoffersen, L., et al. (2014) · Infection and Immunity · doi:10.1128/iai.01969-14 · Cited by 147
Liao, J., Schurr, M. J., & Sauer, K. (2013) · Journal of Bacteriology · doi:10.1128/jb.00318-13 · Cited by 145
Photodynamic Inactivation of Bacterial and Yeast Biofilms With a Cationic Porphyrin
Beirão, S., Fernandes, S., Coelho, J., Faustino, M. A. F., Tomé, J. P. C., Neves, M. G. P. M. S., Tomé, A. C., Almeida, A., & Cunha, Â. (2014) · Photochemistry and Photobiology · doi:10.1111/php.12331 · Cited by 140
Rossi, E., Falcone, M., Molin, S., & Johansen, H. K. (2018) · Nature Communications · doi:10.1038/s41467-018-05944-5 · Cited by 137
Ahmed, M. N., Porse, A., Sommer, M. O. A., Høiby, N., & Ciofu, O. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00320-18 · Cited by 134
Santi, I., Manfredi, P., Maffei, E., Egli, A., & Jenal, U. (2021) · mBio · doi:10.1128/mbio.03482-20 · Cited by 123
Antibiotic-induced genetic variation: how it arises and how it can Be prevented
Blázquez, J., Rodríguez-Beltrán, J., & Matic, I. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062139 · Cited by 122
Sadovskaya, I., Vinogradov, E., Li, J., Hachani, A., Kowalska, K., & Filloux, A. (2010) · Glycobiology · doi:10.1093/glycob/cwq047 · Cited by 115
Martins, D., McKay, G., Sampathkumar, G., Khakimova, M., English, A. M., & Nguyen, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804525115 · Cited by 114
Current progress and prospects of organic nanoparticles against bacterial biofilm
Li, X., Chen, D., & Xie, S. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102475 · Cited by 109
Parallel evolution of tobramycin resistance across species and environments
Scribner, M. R., Santos-Lopez, A., Marshall, C. W., Deitrick, C., & Cooper, V. S. (2020) · mBio · doi:10.1128/mbio.00932-20 · Cited by 103
The MerR-Like Transcriptional Regulator BrlR Contributes to Pseudomonas aeruginosa Biofilm Tolerance
Liao, J., & Sauer, K. (2012) · Journal of Bacteriology · doi:10.1128/jb.00765-12 · Cited by 99
Kordes, A., Preusse, M., Willger, S. D., Braubach, P., Jonigk, D., Haverich, A., Warnecke, G., & Häussler, S. (2019) · Nature Communications · doi:10.1038/s41467-019-11414-3 · Cited by 97
Beaudoin, T., Zhang, L., Hinz, A. J., Parr, C. J., & Mah, T.-F. (2012) · Journal of Bacteriology · doi:10.1128/jb.06178-11 · Cited by 94
Pérez-Laguna, V., García, I., Ballesta, S., Pérez-Artiaga, L., Lampaya-Pérez, V., Rezusta, A., & Gilaberte, Y. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101810 · Cited by 93
Kolpen, M., Kühl, M., Bjarnsholt, T., Moser, C., Hansen, C. R., Liengaard, L., Kharazmi, A., Pressler, T., Høiby, N., & Jensen, P. Ø. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084353 · Cited by 92
Macia, M. D., Borrell, N., Segura, M., Gómez, C., Pérez, J. L., & Oliver, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.975-983.2006 · Cited by 87
Self-citationMontanari, S., Oliver, A., Salerno, P., Mena, A., Bertoni, G., Tümmler, B., Cariani, L., Conese, M., Döring, G., & Bragonzi, A. (2007) · Microbiology · doi:10.1099/mic.0.2006/003400-0 · Cited by 87
Self-citationJensen, P. Ø., Briales, A., Brochmann, R. P., Wang, H., Kragh, K. N., Kolpen, M., Hempel, C., Bjarnsholt, T., Høiby, N., & Ciofu, O. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12120 · Cited by 86
RADMAN, M., MATIC, I., & TADDEI, F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08874.x · Cited by 81
Hypoxia, innate immunity and infection in the lung
Schaible, B., Schaffer, K., & Taylor, C. T. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.006 · Cited by 77
Andersen, J. B., Hultqvist, L. D., Jansen, C. U., Jakobsen, T. H., Nilsson, M., Rybtke, M., Uhd, J., Fritz, B. G., Seifert, R., Berthelsen, J., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00225-4 · Cited by 77
Chiang, W.-C., Pamp, S. J., Nilsson, M., Givskov, M., & Tolker-Nielsen, T. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00929.x · Cited by 71
Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants
Mulet, X., Maciá, M. D., Mena, A., Juan, C., Pérez, J. L., & Oliver, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01264-08 · Cited by 71
Self-citationBrochmann, R. P., Toft, A., Ciofu, O., Briales, A., Kolpen, M., Hempel, C., Bjarnsholt, T., Høiby, N., & Jensen, P. Ø. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.015 · Cited by 68
Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model
Cao, B., Christophersen, L., Thomsen, K., Sønderholm, M., Bjarnsholt, T., Jensen, P. Ø., Høiby, N., & Moser, C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv058 · Cited by 68
Lin, Q., Pilewski, J. M., & Di, Y. P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.747834 · Cited by 65
CRISPR interference to interrogate genes that control biofilm formation in Pseudomonas fluorescens
Noirot-Gros, M.-F., Forrester, S., Malato, G., Larsen, P. E., & Noirot, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-52400-5 · Cited by 65
Poole, K. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0666 · Cited by 64
Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance?
Blazquez, J., Oliver, A., & Gomez-Gomez, J.-M. (2002) · Current Drug Targets · doi:10.2174/1389450023347579 · Cited by 63
Self-citationBiofilm antimicrobial susceptibility through an experimental evolutionary lens
Coenye, T., Bové, M., & Bjarnsholt, T. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00346-4 · Cited by 62
Gutiérrez, O., Juan, C., Pérez, J. L., & Oliver, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3573-3575.2004 · Cited by 61
Self-citationGiwercman, B., Meyer, C., Lambert, P. A., Reinert, C., & Høiby, N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.71 · Cited by 60
Poudyal, B., & Sauer, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01981-17 · Cited by 59
Lerche, C. J., Christophersen, L. J., Kolpen, M., Nielsen, P. R., Trøstrup, H., Thomsen, K., Hyldegaard, O., Bundgaard, H., Jensen, P. Ø., Høiby, N., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.025 · Cited by 59
Kenna, D. T., Doherty, C. J., Foweraker, J., Macaskill, L., Barcus, V. A., & Govan, J. R. W. (2007) · Microbiology · doi:10.1099/mic.0.2006/005082-0 · Cited by 57
Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model
Cao, B., Christophersen, L., Kolpen, M., Jensen, P. Ø., Sneppen, K., Høiby, N., Moser, C., & Sams, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153616 · Cited by 56
Ahmed, M. N., Abdelsamad, A., Wassermann, T., Porse, A., Becker, J., Sommer, M. O. A., Høiby, N., & Ciofu, O. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00138-8 · Cited by 56
Rojo‐Molinero, E., Macia, M. D., Rubio, R., Moyá, B., Cabot, G., López-Causapé, C., Pérez, J. L., Cantón, R., & Oliver, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-16 · Cited by 49
Self-citationBiofilms preserve the transmissibility of a multi-drug resistance plasmid
Metzger, G. A., Ridenhour, B. J., France, M., Gliniewicz, K., Millstein, J., Settles, M. L., Forney, L. J., Stalder, T., & Top, E. M. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00357-1 · Cited by 47
Plasencia, V., Borrell, N., Macia, M. D., Moyá, B., Pérez, J. L., & Oliver, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-07 · Cited by 47
Self-citationKolpen, M., Appeldorff, C. F., Brandt, S., Mousavi, N., Kragh, K. N., Aydogan, S., Uppal, H. A., Bjarnsholt, T., Ciofu, O., Høiby, N., et al. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftv086 · Cited by 46
Skov, M., Pressler, T., Lykkesfeldt, J., Poulsen, H. E., Jensen, P. Ø., Johansen, H. K., Qvist, T., Kræmer, D., Høiby, N., & Ciofu, O. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.09.015 · Cited by 44
Zaborskyte, G., Andersen, J. B., Kragh, K. N., & Ciofu, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02292-16 · Cited by 42
Díez-Aguilar, M., Morosini, M. I., Tedim, A. P., Rodríguez, I., Aktaş, Z., & Cantón, R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00822-15 · Cited by 37
Müsken, M., Pawar, V., Schwebs, T., Bähre, H., Felgner, S., Weiß, S., & Häußler, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01635-18 · Cited by 35
Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms
Haagensen, J., Verotta, D., Huang, L., Engel, J., Spormann, A. M., & Yang, K. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx288 · Cited by 34
López-Causapé, C., Maruri-Aransolo, A., Gomis-Font, M. A., Penev, I., Castillo, M. G., Mulet, X., de Dios Caballero, J., Campo, R. D., Cantón, R., & Oliver, A. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.11.014 · Cited by 34
Self-citationBiofilms can act as plasmid reserves in the absence of plasmid specific selection
Røder, H. L., Trivedi, U., Russel, J., Kragh, K. N., Herschend, J., Thalsø-Madsen, I., Tolker-Nielsen, T., Bjarnsholt, T., Burmølle, M., & Madsen, J. S. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00249-w · Cited by 31
Bilal, H., Bergen, P. J., Kim, T. H., Chung, S. E., Peleg, A. Y., Oliver, A., Nation, R. L., & Landersdorfer, C. B. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01293-19 · Cited by 31
Self-citationTargeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria
Donnert, M., Elsheikh, S., Arce‐Rodríguez, A., Pawar, V., Braubach, P., Jonigk, D. D., Haverich, A., Weiß, S., Müsken, M., & Häußler, S. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009126 · Cited by 28
Ghosh, S., Lahiri, D., Nag, M., Sarkar, T., Pati, S., Edinur, H. A., Kumar, M., Zain, M. R. A. M., & Ray, R. R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.964848 · Cited by 26
Social behavior of antibiotic resistant mutants within Pseudomonas aeruginosa biofilm communities
Rojo-Molinero, E., Macià, M. D., & Oliver, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00570 · Cited by 26
Self-citationRodríguez-Rojas, A., Couce, A., & Blázquez, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00415-10 · Cited by 26
Krajewski, J., Bode‐Böger, S. M., Tröger, U., Martens‐Lobenhoffer, J., Mulrooney, T., Mittelstaedt, H., Russlies, M., Kirchner, R., & Knobloch, J. K. ‐. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.023 · Cited by 25
Christophersen, L., Schwartz, F. A., Lerche, C. J., Svanekjær, T., Kragh, K. N., Laulund, A. S., Thomsen, K., Henneberg, K.-Å., Sams, T., Høiby, N., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.01.009 · Cited by 24
Gade, P. A. V., Olsen, T. B., Jensen, P. Ø., Kolpen, M., Høiby, N., Henneberg, K.-Å., & Sams, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198909 · Cited by 22
Bao, X., Bové, M., & Coenye, T. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01875-21 · Cited by 19
Kvich, L., Christensen, M. H., Pierchała, M. K., Astafiev, K. F., Lou-Moeller, R., & Bjarnsholt, T. (2022) · Antibiotics · doi:10.3390/antibiotics11111494 · Cited by 17
Bilal, H., Bergen, P. J., Tait, J. R., Wallis, S. C., Peleg, A. Y., Roberts, J. A., Oliver, A., Nation, R. L., & Landersdorfer, C. B. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00469-20 · Cited by 13
Self-citationEvolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections
Oliver, A., Mena, A., & Maciá, M. D. (2014) · Evolutionary Biology of Bacterial and Fungal Pathogens · doi:10.1128/9781555815639.ch36 · Cited by 8
Self-citationKolpen, M., Appeldorff, C. F., Brandt, S., Mousavi, N., Kragh, K. N., Aydogan, S., Uppal, H. A., Bjarnsholt, T., Ciofu, O., Høiby, N., et al. (2015) · doi:10.13140/rg.2.1.2104.1360 · Cited by 4
Cited by
Halawa, E. M., Fadel, M., Al-Rabia, M. W., Behairy, A., Nouh, N. A., Abdo, M., Olga, R., Fericean, L., Atwa, A. M., El-Nablaway, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1305294 · Cited by 280
Advanced Nanoparticles in Combating Antibiotic Resistance: Current Innovations and Future Directions
AlQurashi, D. M., AlQurashi, T. F., Alam, R. I., Shaikh, S., & Tarkistani, M. A. M. (2025) · Journal of Nanotheranostics · doi:10.3390/jnt6020009 · Cited by 132
Bonincontro, G., Scuderi, S. A., Marino, A., & Simonetti, G. (2023) · Pharmaceuticals · doi:10.3390/ph16111531 · Cited by 91
Biofilm formation and antibiotic resistance in Pseudomonas aeruginosa
Haidar, A., Muazzam, A., Nadeem, A., Atique, R., Saeed, H. A., Naveed, A., Sharif, J., Perveen, A., Fatima, H. R., & Samad, A. (2024) · The Microbe · doi:10.1016/j.microb.2024.100078 · Cited by 85
Biofilms: structure, resistance mechanism, emerging control strategies, and applications
Ugwu, C. N., Ezeibe, E. N., Emencheta, S. C., Nwagwu, C. S., Ogbonna, K. O., Ejiofor, C. V., Onugwu, A. L., BEREBON, D. P., & Attama, A. A. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00094g · Cited by 72
Metadata
- Authors
- Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Venue
- Biofilm
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 5
- Pages
- 100129
- ISSN
- 2590-2075 (ISSN-L)
- PMC
- PMC10189392
- OpenAlex
- W4367693161
- Cited by
- 170
- References
- 136
- Citations by year
- 2026: 65 · 2025: 64 · 2024: 34 · 2023: 7
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Biofilm (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (2322/2746)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Pseudomonas aeruginosa, biofilm, antibiotic resistance, spontaneous mutation rate, chronic infection, chronic lung infection, antimicrobial therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Fig. 1 Mechanisms of antimicrobial tolerance and resistance found in biofilms and antibiotics affected by them. FQ: Fluoroquinolones; AMG: Aminoglycosides; AZT: Azitromycin; LPS: lipopolysaccharide. Figure adapted from Ciofu O et al., Nat rev, 2022 [62].](https://figures.cochat.ai/paper-figures/9868f8e636334ecababe5458f56b6d16/mechanisms-of-antibiotic-resistance-in-pseudomonas-aeruginosa-biofilms-figure-1.jpg)